Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein overexpressed in PCa with expression levels correlating to tumor aggressiveness, has emerged as a cornerstone for precision theranostics. The gene discussed is FOLH1; the disease is posterior cortical atrophy.